September 3, 2026
The Minnesota Department of Health (MDH), in collaboration with the MMA and partner physicians, has released an informational brief on concentrated 7‑hydroxymitragynine (7‑OH) and other kratom products, which are increasingly available in commercial forms such as tablets, gummies, liquids, and “enhanced” or “spiked” kratom products.
The brief provides information for clinicians, including:
awareness of the DEA’s temporary scheduling of substances related to 7‑OH,
information on how concentrated 7‑OH products may produce stronger opioid‑like effects than typical kratom products, and
considerations for clinical settings that may encounter patients presenting with intoxication or withdrawal associated with these products.
The brief is intended to support situational awareness and preparedness across Minnesota healthcare settings. Please share across clinical teams.
October 15, 2026
In an October 2 letter to the CMS, temporary Commissioner and State Medicaid Director for Minnesota DHS John Connolly asked for resolution on several outstanding points of disagreement.
October 15, 2026
The MMA will host two virtual forums in November on medical liability trends in Minnesota, and how H.R. 1 is reshaping Minnesota's healthcare landscape.
October 15, 2026
Medical students, residents, and fellows are encouraged to apply for MMA Foundation scholarship grants supporting primary care, physician well-being, health equity, and advocacy.